CBC now testing for Zika virus, per FDA guidelines


Submitted story



DAYTON – Community Blood Center is now testing blood donations for the Zika virus in compliance with recommendations issued by the U.S. Food and Drug Administration to protect the blood supply.

In August the FDA recommended universal testing of all donated whole blood and blood components for the Zika virus in the United States and its territories. Ohio and Indiana are among the states that were scheduled to begin testing by Nov. 18 or sooner. CBC began testing Monday, Nov. 14.

CBC is no longer deferring donors for travel to Zika endemic areas.

The new Zika testing system is investigational and all donations submitted for testing are part of a research study. By consenting to give blood, donors are agreeing to participate in the research study. The results from the study will help develop better testing systems to protect the blood supply.

CBC will notify the donor if results are positive. Donors with a test result that indicates a Zika infection should discuss the results with their primary care physician. CBC will defer donors with positive test results for 120 days from the date of the test or the resolution of symptoms, whichever time frame is longer.

CBC reminds donors that non-Zika related travel restrictions still apply. They can impact the available blood supply by limiting the number of people able to donate. CBC encourages eligible donors to schedule appointments and donate when able.

Learn more at www.GivingBlood.org

Connect with Community Blood Center for the latest information and services at www.GivingBlood.org. Get fast and complete answers on how to make your first donation, organize a blood drive, or bring our education program to your school. Get all the updates in the CBC/CTS newsroom, find quick links to our social media pages, or schedule your next appointment to donate by connecting to www.DonorTime.com.

Submitted story

Submitted by the Community Blood Center.

Submitted by the Community Blood Center.